Protagonist Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
PTGX
CUSIP
74366E102
Type
Equity
Class
COM
Num filings
290
Total reported value, excl. options
$3.95 B
Manager Report Date Value ($000) Shares Option Type